Article Versions Notes

Ansari UA, Srivastava A, Srivastava AK, Pandeya A, Vatsa P, Negi R, Singh A, Pant AB. Targeting TDP-43 Proteinopathy in hiPSC-Derived Mutated hNPCs with Mitoxantrone Drugs and miRNAs. Pharmaceutics. 2025; 17(4):410. https://doi.org/10.3390/pharmaceutics17040410

Ansari, Uzair A., Ankita Srivastava, Ankur K. Srivastava, Abhishek Pandeya, Pankhi Vatsa, Renu Negi, Akash Singh, and Aditya B. Pant. 2025. "Targeting TDP-43 Proteinopathy in hiPSC-Derived Mutated hNPCs with Mitoxantrone Drugs and miRNAs" Pharmaceutics 17, no. 4: 410. https://doi.org/10.3390/pharmaceutics17040410

Ansari, U. A., Srivastava, A., Srivastava, A. K., Pandeya, A., Vatsa, P., Negi, R., Singh, A., & Pant, A. B. (2025). Targeting TDP-43 Proteinopathy in hiPSC-Derived Mutated hNPCs with Mitoxantrone Drugs and miRNAs. Pharmaceutics, 17(4), 410. https://doi.org/10.3390/pharmaceutics17040410